101 – 200 of 247
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: comment on the article by Young-Min et al - Reply
(
- Contribution to journal › Letter
-
Mark
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
(
- Contribution to journal › Published meeting abstract
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
-
Mark
Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement
(
- Contribution to journal › Article
- 2007
-
Mark
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab
(
- Contribution to journal › Letter
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
(
- Contribution to journal › Article
-
Mark
The impact of IL-1Ra and MBL gene polymorphisms on joint damage after 5 and 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
(
- Contribution to journal › Scientific review
-
Mark
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
(
- Contribution to journal › Article
-
Mark
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
-
Mark
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
(
- Contribution to journal › Article
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2006
-
Mark
Classification of osteoarthritis biomarkers: a proposed approach
(
- Contribution to journal › Scientific review
-
Mark
The heritable determinants of cartilage oligomeric matrix protein
(
- Contribution to journal › Article
-
Mark
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis
(
- Contribution to journal › Article
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
Non-collagenous Proteins; Glycoproteins and related proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Biomarkers for cartilage and bone in rheumatoid arthritis
2006) p.301-301(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
-
Mark
Noncollagenous Proteins: Glycoproteins and Related Proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Glukosamin hjälper inte mot smärta vid knäartros
(
- Contribution to journal › Letter
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Prediction of mortality in rheumatoid arthritis based on disease activity markers.
(
- Contribution to journal › Article
-
Mark
No increase of severe infections in RA patients treated with TNF-blockers
2005) Annual European Congress of Rheumatology, 2005 In Annals of the Rheumatic Diseases 64(Suppl. 3). p.461-462(
- Contribution to journal › Published meeting abstract
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
(
- Contribution to journal › Letter
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Changes of cartilage and bone markers after intraarticular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis
(
- Contribution to journal › Article
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
- 2004
-
Mark
Hormone replacement therapy, calcium and vitamin D-3 versus calcium and vitamin D-3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
(
- Contribution to journal › Article
-
Mark
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.
(
- Contribution to journal › Article
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
(
- Contribution to journal › Letter
-
Mark
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
(
- Contribution to journal › Article
- 2003
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
-
Mark
Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Recent developments and future research in the bone and joint decade 2000-2010.
(
- Contribution to journal › Letter
-
Mark
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.
(
- Contribution to journal › Article
-
Mark
Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Inflammation is a feature of the disease process in early knee joint osteoarthritis.
(
- Contribution to journal › Letter
-
Mark
Cyclosporin A in rheumatoid arthritis
(
- Contribution to journal › Letter
- 2002
-
Mark
Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
(
- Contribution to journal › Article
-
Mark
Förlegat beskriva artros som "degenerativ ledsjukdom"
(
- Contribution to journal › Letter
-
Mark
Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Behandling med TNF-hämmare vid reumatoid artrit
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
2002) p.285-292(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Association of chondroadherin with collagen type II
(
- Contribution to journal › Article
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cytokines, metalloproteinase, their inhibitors, and COMP: relation to radiological progression and inflammation in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis in rats
(
- Contribution to journal › Article
-
Mark
Diagnosis of osteoarthritis in relation to molecular processes in cartilage: comment on the article by Clark et al.
(
- Contribution to journal › Article
-
Mark
Molecular markers for assessment of cartilage damage in rheumatoid arthritis
2000) p.291-304(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis
(
- Contribution to journal › Article
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nya läkemedel mot reumatoid artrit : Förbättrade behandlingsmöjligheter ställer nya krav på sjukvårdsorganisationen
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation
(
- Contribution to journal › Article
-
Mark
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis
(
- Contribution to journal › Article
-
Mark
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978
(
- Contribution to journal › Article
-
Mark
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
(
- Contribution to journal › Article
-
Mark
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
(
- Contribution to journal › Article
- 1998
-
Mark
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
(
- Contribution to journal › Article
-
Mark
Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
(
- Contribution to journal › Article
-
Mark
Joint space width in the axial view of the patello-femoral joint: Definitions and comparisons with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study.
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
(
- Contribution to journal › Article
-
Mark
Cartilage markers in synovial fluid in symptomatic knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Serum biological markers as predictors of disease progression in osteoarthritis of the knee
(
- Contribution to journal › Letter
-
Mark
HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain.
(
- Contribution to journal › Article
-
Mark
Cartilage matrix macromolecules in joint fluid of temporomandibular joints before and six months after diskectomy
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules and the development of new methods for the assessment of joint disease
(
- Contribution to journal › Article
-
Mark
Serum analyses of tissue derived macromolecules and markers of inflammation in early rheumatoid arthritis. Relation to development of joint destructions in hands and feet
(
- Contribution to journal › Article
-
Mark
Postero-anterior radiogram of the knee in weightbearing and semiflexion. Comparison with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules in knee synovial fluid. Markers of the disease course in patients with acute oligoarthritis
(
- Contribution to journal › Article